menu ☰
menu ˟

Docetaxel plus cyclophosphamide fails to meet non-inferiority vs. anthracycline/taxane chemotherapy

21 Jul 2016
At the 2016 ASCO Annual Meeting, Adam M. Brufsky, MD, PhD, professor of medicine, associate chief of hematology/oncology and co-director of the comprehensive breast cancer center at the University of Pittsburgh, spoke with HemOnc Today about the data...

Click here to view the full article which appeared in Hematology Oncology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.